Literature DB >> 20007576

Inflation and long-term maintenance of CD8 T cells responding to a latent herpesvirus depend upon establishment of latency and presence of viral antigens.

Anna Lang1, James D Brien, Janko Nikolich-Zugich.   

Abstract

Following the priming and contraction phases of the T cell response, latent persistent herpesviruses lead to an accumulation of large pools of virus-specific CD8 T cells, also known as memory inflation (MI). The mechanism of this inflation is incompletely understood, largely because the molecular reactivation of these viruses in vivo and its impact upon T cell biology have not been resolved in mice, and because the relevant observations in humans remain, by necessity, correlative. Understanding these processes is essential from the standpoint of the proposed critical role for latent herpesviruses in aging of the immune system. We studied the causes of memory CD8 T cell accumulation following systemic HSV-1 administration as a model of widespread latent viral infection in humans. A direct role of viral latency and Ag-specific restimulation in driving the accumulation and maintenance of inflated CD8 T cells and a strongly suggested role of viral reactivation in that process were shown by the following: 1) lack of MI in the absence of established latency; 2) prevention or delay of MI with drugs that curtail viral replication; and 3) abrogation of MI by the transfer of inflated T cells into a virus-free environment. These results strongly suggest that periodic, subclinical reactivations of a latent persistent virus cause dysregulation of memory CD8 T cell homeostasis, similar to the one in humans. Moreover, results with antiviral drugs suggest that this approach could be considered as a treatment modality for maintaining T cell diversity and/or function in old age.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20007576      PMCID: PMC4161222          DOI: 10.4049/jimmunol.0801117

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs.

Authors:  R Holtappels; M F Pahl-Seibert; D Thomas; M J Reddehase
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Herpes simplex virus-specific CD8+ T cells can clear established lytic infections from skin and nerves and can partially limit the early spread of virus after cutaneous inoculation.

Authors:  Allison van Lint; Margaret Ayers; Andrew G Brooks; Richard M Coles; William R Heath; Francis R Carbone
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

3.  Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old.

Authors:  Qin Ouyang; Wolfgang M Wagner; Anders Wikby; Steffen Walter; Geraldine Aubert; Anthony I Dodi; Paul Travers; Graham Pawelec
Journal:  J Clin Immunol       Date:  2003-07       Impact factor: 8.317

4.  Dysfunctional CMV-specific CD8(+) T cells accumulate in the elderly.

Authors:  Qin Ouyang; Wolfgang M Wagner; Wei Zheng; Anders Wikby; Ed J Remarque; Graham Pawelec
Journal:  Exp Gerontol       Date:  2004-04       Impact factor: 4.032

5.  Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection.

Authors:  J Podlech; R Holtappels; M F Pahl-Seibert; H P Steffens; M J Reddehase
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Characterization of two TCR transgenic mouse lines specific for herpes simplex virus.

Authors:  Scott N Mueller; WilliamR Heath; Julie D McLain; Francis R Carbone; Claerwen M Jones
Journal:  Immunol Cell Biol       Date:  2002-04       Impact factor: 5.126

7.  Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells.

Authors:  Christopher M Snyder; Kathy S Cho; Elizabeth L Bonnett; Serani van Dommelen; Geoffrey R Shellam; Ann B Hill
Journal:  Immunity       Date:  2008-10-17       Impact factor: 31.745

8.  Memory inflation: continuous accumulation of antiviral CD8+ T cells over time.

Authors:  Urs Karrer; Sophie Sierro; Markus Wagner; Annette Oxenius; Hartmut Hengel; Ulrich H Koszinowski; Rodney E Phillips; Paul Klenerman
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

9.  Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1).

Authors:  Qin Ouyang; Wolfgang M Wagner; David Voehringer; Anders Wikby; Tatjana Klatt; Steffen Walter; Claudia A Müller; Hanspeter Pircher; Graham Pawelec
Journal:  Exp Gerontol       Date:  2003-08       Impact factor: 4.032

10.  Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses.

Authors:  Urs Karrer; Markus Wagner; Sophie Sierro; Annette Oxenius; Hartmut Hengel; Tilman Dumrese; Stefan Freigang; Ulrich H Koszinowski; Rodney E Phillips; Paul Klenerman
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

View more
  24 in total

Review 1.  Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.

Authors:  Michael L Freeman; Michael M Lederman; Sara Gianella
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

Review 2.  Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.

Authors:  Rebecca Pavlos; Simon Mallal; David Ostrov; Yuri Pompeu; Elizabeth Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2014 Jan-Feb

Review 3.  Age-related changes in CD8 T cell homeostasis and immunity to infection.

Authors:  Janko Nikolich-Žugich; Gang Li; Jennifer L Uhrlaub; Kristin R Renkema; Megan J Smithey
Journal:  Semin Immunol       Date:  2012-05-01       Impact factor: 11.130

Review 4.  Impact of CMV upon immune aging: facts and fiction.

Authors:  Mladen Jergović; Nico A Contreras; Janko Nikolich-Žugich
Journal:  Med Microbiol Immunol       Date:  2019-04-19       Impact factor: 3.402

5.  Altered populations of natural killer cells, cytotoxic T lymphocytes, and regulatory T cells in major depressive disorder: Association with sleep disturbance.

Authors:  Hideo Suzuki; Jonathan Savitz; T Kent Teague; Siva K Gandhapudi; Chibing Tan; Masaya Misaki; Brett A McKinney; Michael R Irwin; Wayne C Drevets; Jerzy Bodurka
Journal:  Brain Behav Immun       Date:  2017-06-20       Impact factor: 7.217

6.  Functional CD8 T cell memory responding to persistent latent infection is maintained for life.

Authors:  Anna Lang; Janko Nikolich-Zugich
Journal:  J Immunol       Date:  2011-09-02       Impact factor: 5.422

7.  Antiviral therapy can reverse the development of immune senescence in elderly mice with latent cytomegalovirus infection.

Authors:  Mark Beswick; Annette Pachnio; Sarah N Lauder; Clive Sweet; Paul A Moss
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

Review 8.  Immunity to acute virus infections with advanced age.

Authors:  Janko Nikolich-Žugich; Christine M Bradshaw; Jennifer L Uhrlaub; Makiko Watanabe
Journal:  Curr Opin Virol       Date:  2020-11-04       Impact factor: 7.090

9.  A new model for CD8+ T cell memory inflation based upon a recombinant adenoviral vector.

Authors:  Beatrice Bolinger; Stuart Sims; Geraldine O'Hara; Catherine de Lara; Elma Tchilian; Sonja Firner; Daniel Engeler; Burkhard Ludewig; Paul Klenerman
Journal:  J Immunol       Date:  2013-03-18       Impact factor: 5.422

10.  Cytomegalovirus (CMV) Epitope-Specific CD4+ T Cells Are Inflated in HIV+ CMV+ Subjects.

Authors:  Chike O Abana; Mark A Pilkinton; Silvana Gaudieri; Abha Chopra; Wyatt J McDonnell; Celestine Wanjalla; Louise Barnett; Rama Gangula; Cindy Hager; Dae K Jung; Brian G Engelhardt; Madan H Jagasia; Paul Klenerman; Elizabeth J Phillips; David M Koelle; Spyros A Kalams; Simon A Mallal
Journal:  J Immunol       Date:  2017-10-02       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.